We are live on ! Find out more
OPCM

Osborne Partners Capital Management Portfolio holdings

AUM $1.8B
1-Year Est. Return 22.23%
This Fund
S&P 500
This Quarter Est. Return
+0.92%
1 Year Est. Return
+22.23%
3 Year Est. Return
+60.75%
5 Year Est. Return
+67.79%
10 Year Est. Return
+286.62%
AUM
$774M
AUM Growth
-$3.04M
Cap. Flow
-$6.68M
Cap. Flow %
-0.86%
Top 10 Hldgs %
27.35%
Holding
180
New
5
Increased
37
Reduced
81
Closed
4

Top Sells

Rank Stock Value
1
APD icon
Air Products & Chemicals
APD
+$7.42M
2
WBD icon
Warner Bros
WBD
+$2.1M
3
DHR icon
Danaher
DHR
+$590K
4
BP icon
BP
BP
+$508K
5
AMG icon
Affiliated Managers Group
AMG
+$348K

Sector Composition

Rank Sector Weight
1 Technology 14.36%
2 Healthcare 13.67%
3 Financials 12.01%
4 Consumer Staples 10.65%
5 Energy 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZBH icon
101
Zimmer Biomet
ZBH
$18.4B
$1.23M 0.16%
12,607
-561
-4% -$55.2K
BIIB icon
102
Biogen
BIIB
$30.7B
$1.22M 0.16%
3,701
-35
-0.9% -$11.5K
PNW icon
103
Pinnacle West Capital
PNW
$12.2B
$1.19M 0.15%
21,695
MRK icon
104
Merck
MRK
$318B
$1.16M 0.15%
20,533
-1,227
-6% -$68.9K
APD icon
105
Air Products & Chemicals
APD
$67.6B
$1.13M 0.15%
9,395
-60,715
-87% -$7.42M
KMI icon
106
Kinder Morgan
KMI
$68.7B
$999K 0.13%
26,050
-910
-3% -$34.6K
CAG icon
107
Conagra Brands
CAG
$7.23B
$927K 0.12%
36,064
-1,079
-3% -$26.6K
VOD icon
108
Vodafone
VOD
$37.4B
$916K 0.12%
27,837
-2,762
-9% -$92.1K
KRFT
109
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$874K 0.11%
15,495
-222
-1% -$12.8K
PBE icon
110
Invesco Biotechnology & Genome ETF
PBE
$353M
$863K 0.11%
18,670
APU
111
DELISTED
AmeriGas Partners, L.P.
APU
$855K 0.11%
18,748
MMM icon
112
3M
MMM
$94.3B
$832K 0.11%
7,023
-120
-2% -$14.4K
DNB
113
DELISTED
Dun & Bradstreet
DNB
$727K 0.09%
6,185
V icon
114
Visa
V
$677B
$687K 0.09%
12,884
-340
-3% -$18.3K
AEE icon
115
Ameren
AEE
$30.1B
$685K 0.09%
17,863
+150
+0.8% +$5.87K
NBL
116
DELISTED
Noble Energy, Inc.
NBL
$684K 0.09%
10,000
COP icon
117
ConocoPhillips
COP
$141B
$664K 0.09%
8,684
-3,294
-28% -$270K
VTI icon
118
Vanguard Morningstar Total Stock Market ETF
VTI
$691B
$623K 0.08%
6,150
+260
+4% +$26.6K
USB icon
119
US Bancorp
USB
$99.6B
$608K 0.08%
14,527
KTCC icon
120
Key Tronic
KTCC
$44.7M
$606K 0.08%
57,300
MCO icon
121
Moody's
MCO
$82.7B
$567K 0.07%
6,000
CMCSA icon
122
Comcast
CMCSA
$90B
$535K 0.07%
19,902
+600
+3% +$16.4K
HE icon
123
Hawaiian Electric Industries
HE
$2.14B
$519K 0.07%
19,530
-500
-2% -$12.4K
XEL icon
124
Xcel Energy
XEL
$48.8B
$479K 0.06%
15,745
EOG icon
125
EOG Resources
EOG
$70.7B
$474K 0.06%
4,790

Similar funds

Osborne Partners Capital Management's Q3 2014 Portfolio in Review

As of Q3 2014, Osborne Partners Capital Management held 180 positions worth $774M, down 0.39% from $777M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Osborne Partners Capital Management's Q3 2014 filing shows 5 new, 37 increased, 81 reduced and 4 closed positions. Its largest new stake was Trinity Industries: 63,123 shares worth $2.12M. The largest sale was Air Products & Chemicals, an estimated $7.42M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Osborne Partners Capital Management's largest Q3 2014 buy was Trinity Industries: 63,123 shares worth $2.12M.
  • Osborne Partners Capital Management added most to Marsh in Q3 2014, an estimated $2.45M increase.
  • Osborne Partners Capital Management's biggest Q3 2014 reduction was Air Products & Chemicals, cutting an estimated $7.42M.
  • Osborne Partners Capital Management fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q3 2014, selling an estimated $201K.
  • Osborne Partners Capital Management's ten largest holdings make up 27% of its $774M portfolio in Q3 2014.
  • Osborne Partners Capital Management opened 5 new positions and closed 4 in Q3 2014.
  • Osborne Partners Capital Management's portfolio value fell 0.39% quarter-over-quarter to $774M.

Based on Osborne Partners Capital Management's 13F filing for Q3 2014, filed 22 Oct 2014.